Algeria vs Cape Verde: Previously treated cases tested for RR-/MDR-TB
Algeria
8.2%
in 2023
Cape Verde
20.0%
in 2024
Algeria rank
168th
Cape Verde rank
165th
Previously treated cases tested for RR-/MDR-TB over time
- Algeria
- Cape Verde
How they compare
Cape Verde currently reports 20.0% against 8.2% in Algeria, a difference of 11.8%.
That makes Cape Verde's figure about 2.4 times Algeria's.
The two have swapped places 3 times across 8 shared years of data; in 2015 it was Algeria ahead.
Algeria ranks 168th and Cape Verde ranks 165th of 180 countries.
Across the 2 decades both report, Algeria averaged higher in 1 and Cape Verde in 1.
Head to head by decade
| Decade | Algeria | Cape Verde | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 39.7% | 30.2% | 9.5% | Algeria |
| 2020s | 20.7% | 64.3% | 43.6% | Cape Verde |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Algeria or Cape Verde?
- Cape Verde, at 20.0% against 8.2% in Algeria as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Algeria and Cape Verde?
- 11.8%, with Cape Verde ahead.
- How many years of comparable data are there for Algeria and Cape Verde?
- 8 years are reported by both, from 2015 to 2023.
- How do Algeria and Cape Verde rank globally for previously treated cases tested for rr-/mdr-tb?
- Algeria ranks 168th and Cape Verde ranks 165th of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.